FeesSafety
Pluang+

V2X unveils advanced defense tech at AUSA 2026 to boost battlefield security and readiness.

Market News
06 Oct 2026, 14:30 WIB
PRNewsWire
View Source
Bullish
V2X unveils advanced defense tech at AUSA 2026 to boost battlefield security and readiness.

V2X, Inc. is showcasing its latest defense technologies at the 2026 Association of the United States Army (AUSA) Annual Meeting, including the Tempest Sentinel Counter-UAS system, AI-driven Cold Steel predictive maintenance platform, integrated Advantor security solutions, and Gateway Mission Router for enhanced air-to-ground communications. These innovations aim to improve protection against drone threats, optimize aircraft readiness, secure critical assets, and enhance battlefield connectivity. This demonstration highlights V2X's commitment to advancing military readiness and operational efficiency through cutting-edge technology.

V2X's advanced technology showcase is the context for this Industrials-sector snapshot on Pluang. For readers following Industrials, here is Pluang's market snapshot as of Oct 06, 2026 18:13 WIB: Out of 93 priced US Industrials stocks, 65 rose and 22 fell. Notable movers include Symbotic Inc (SYM) at USD 43.44 with a 1-day change of +1.33% and Pluang order activity showing 89% Buy, Upwork Inc (UPWK) at USD 8.25 down 1.32% with 60% Sell activity, and GE Vernova Inc (GEV) at USD 1,003.00 up 1.31% with 75% Buy activity.

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
15 minutes ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
15 minutes ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
27 minutes ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
2 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App